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Abstract
Taxadien‐5α‐hydroxylase and taxadien‐5α‐ol O‐acetyltransferase catalyze the oxi-
dation of taxadiene to taxadien‐5α‐ol and subsequent acetylation to taxadien‐5α‐yl‐
acetate in the biosynthesis of the blockbuster anticancer drug, paclitaxel (Taxol®).
Despite decades of research, the promiscuous and multispecific CYP725A4 enzyme
remains a major bottleneck in microbial biosynthetic pathway development. In this
study, an interdisciplinary approach was applied for the construction and optimi-
zation of the early pathway in Saccharomyces cerevisiae, across a range of bioreactor
scales. High‐throughput microscale optimization enhanced total oxygenated taxane
titer to 39.0 ± 5.7 mg/L and total taxane product titers were comparable at micro
and minibioreactor scale at 95.4 ± 18.0 and 98.9 mg/L, respectively. The introduction
of pH control successfully mitigated a reduction of oxygenated taxane production,
enhancing the potential taxadien‐5α‐ol isomer titer to 19.2 mg/L, comparable with
the 23.8 ± 3.7 mg/L achieved at microscale. A combination of bioprocess optimiza-
tion and increased gas chromatography‐mass spectrometry resolution at 1 L bior-
eactor scale facilitated taxadien‐5α‐yl‐acetate detection with a final titer of 3.7 mg/L.
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Total oxygenated taxane titers were improved 2.7‐fold at this scale to 78mg/L, the
highest reported titer in yeast. Critical parameters affecting the productivity of the
engineered strain were identified across a range of scales, providing a foundation for
the development of robust integrated bioprocess control systems.
K E YWORD S
high throughput microbioreactor, Saccharomyces cerevisiae, taxadien‐5‐alpha‐ol
O‐acetyltransferase, taxadien‐5‐hydroxylase, Taxol
1 | INTRODUCTION
Paclitaxel (Taxol®) is one of the most widely administered che-
motherapeutic agents owing to its effectiveness against a vast range
of diseases. Although it is found naturally in the bark of Pacific Yew
(Taxus brevifolia), the destruction of three mature trees is necessary
to yield just 1 g of paclitaxel (McElroy & Jennewein, 2018), rendering
direct extraction unsustainable. Heterologous expression of the
complex biosynthetic pathway using a fast‐growing eukaryotic host
could provide a sustainable solution. However, the pathway is yet
to be fully elucidated and low and variable titers of the early
precursors have been achieved to date (Liu et al., 2016; McElroy &
Jennewein, 2018).
The first committed step in paclitaxel biosynthesis involves the
cyclization of geranylgeranyl diphosphate (GGPP), a product of
the mevalonate pathway, by taxadiene synthase (TASY), yielding
taxa‐4(5),11(12)‐diene (taxadiene) and its structural isomer taxa‐
4(20),11(12)‐diene (iso‐taxadiene) as shown in Figure 1.
Both compounds are substrates for the subsequent enzyme
taxadien‐5α‐hydroxylase (CYP725A4), which is the first of several
cytochrome P450s in the paclitaxel pathway (Jennewein et al., 2004).
The desired product of this first oxidation reaction is taxadien‐5α‐ol
(T5αol), which subsequently undergoes acetylation in the third step
in the pathway in a reaction catalyzed by taxadien‐5‐alpha‐ol
O‐acetyltransferase (TAT), yielding taxa‐4(20),11‐dien‐5α‐yl acetate
(Walker et al., 1999).
Heterologous expression of TASY and CYP725A4 has been ac-
complished using both Saccharomyces cerevisiae (DeJong et al., 2006;
Edgar et al., 2016) and Escherichia coli (Edgar et al., 2016; Sagwan‐
Barkdoll & Anterola, 2018; Yadav, 2014). Although, taxadiene titers
of up to 1 g/L have been achieved in E. coli, when CYP725A4 was
subsequently expressed in the respective strain, a significant drop in
productivity was observed, with a total oxygenated taxane titer of
116mg/L (Ajikumar et al., 2010). An impressive effort was made to
optimize P450 expression and reductase partner interactions in E.
coli, achieving a fivefold improvement in total oxygenated taxanes to
570mg/L (Biggs et al., 2016). However, the overexpression of the
subsequent cytochrome P450s in the paclitaxel pathway is likely to
be very challenging in the prokaryotic host. On the other hand, the
eukaryotic host, S. cerevisiae, possesses the necessary biosynthetic
and redox capabilities for the expression of such enzymes (Engels
et al., 2008). Despite this, the maximum reported taxadiene titers are
eightfold lower in yeast (Nowrouzi et al., 2020). Distributing the early
Taxol metabolic pathway among E. coli and S. cerevisiae facilitated a
total oxygenated taxane titer of 33mg/L (Zhou et al., 2015).
Microbial expression of CYP725A4 has resulted in a wide range
of side products including OCT and iso‐OCT (Figure 1) and the de-
sired T5αol compound was a minor product when expressed in E. coli
(Sagwan‐Barkdoll & Anterola, 2018). Additional studies reported
further unknown monooxygenated and dioxygenated taxane com-
pounds (Edgar et al., 2016; Yadav, 2014). In addition to variations in
the nature of the oxygenated taxanes produced, the ratios of the
products generated differed substantially. Edgar et al. (2016) re-
ported that T5αol comprised between 0% and 25% of the products of
CYP725A4 depending on the microbial host, growth medium, and
extraction procedure used. Variations in process conditions between
these steps may contribute to the observed product distributions.
Despite extensive improvements in the microbial expression of the
first two enzymes in the paclitaxel biosynthetic pathway, progress
toward the construction of the third step has been limited. Early
characterization studies revealed TAT is also multispecific (Walker
et al., 1999). Several isoprenoid alcohols including GGOH and far-
nesol were found to be substrates of the enzyme. Despite this, when
TAT was heterologously expressed along with TASY and CYP725A4 in
E. coli, of the several mono and dioxygenated CYP725A4 products,
only T5αol appeared to undergo acetylation (Edgar et al., 2016).
Traditionally, simple small scale shake flask or microplate cultures
have been exploited for early‐stage bioprocess development (Doran,
1995; Funke et al., 2010). However, such systems offer limited insight
to the nature of the process and there are major discrepancies in
cultivation strategies across scales (Funke et al., 2010). As a result,
their use has often resulted in the selection of suboptimal production
conditions, leading to setbacks at the manufacturing stage (Yu et al.,
2014). Maximizing process understanding during the earliest stages of
bioprocess development is essential to overcome such issues. To
tackle this, scalable high‐throughput screening systems have been
developed, allowing industrial bioreactor conditions to be more closely
mimicked (Back et al., 2016; Funke et al., 2009; Kensy et al., 2009;
Kostov et al., 2001). Through coupling such instruments with a stra-
tegic design of experiments approach, factors can be manipulated to
statistically determine relationships between parameters and perfor-
mance, ensuring quality by design.
This study aimed to develop a robust bioprocess for pacli-
taxel precursor production using S. cerevisiae microbial cell
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factories. State of the art micro and minibioreactor tools were
subsequently employed to characterize and optimize the pathway
for the production of oxygenated paclitaxel precursors across a
range of scales for the first time. Design of experiment strategies
was applied to rapidly determine the key factors affecting pro-
ductivity at microscale, whilst minimizing time and resource
costs. Optimal conditions were then validated using novel scale
down benchtop bioreactors accelerating progress towards pacli-
taxel biosynthesis.
2 | MATERIALS AND METHODS
2.1 | Strain construction
The parent S. cerevisiae strain used in this study, LRS5 (MATa, leu2‐3,
112::HIS3MX6‐GAL1p‐ERG19/GAL10p‐ERG8;ura3‐52::URA3‐GAL1p‐
MvaSA110G/GAL10p‐MvaE [codon optimized]; his3Δ1::hphMX4‐GAL1p‐
ERG12/GAL10p‐IDI1; trp1‐289::TRP1_GAL1p‐CrtE(X.den)/GAL10p‐ERG-
20;YPRCdelta15::NatMX‐GAL1p‐CrtE(opt)/GAL10p‐CrtE; ARS1014::GAL-
F IGURE 1 Engineered biosynthetic
pathway in Saccharomyces cerevisiae. (a) The
pathway highlighted in blue is the native
mevalonate pathway; a product of this is the
universal diterpenoid precursor, GGPP. The
first enzyme in the paclitaxel pathway
(highlighted in red), TASY catalyzes the
conversion of GGPP yielding taxadiene and
small amounts of its isomer iso‐taxadiene. The
second enzyme CYP725A4, coupled with its
cognate reductase subsequently catalyzes the
oxidation of taxadiene to T5αol. The third
enzyme, TAT, then catalyzes the acetylation of
T5αol. Native, overexpressed genes are
highlighted in blue whilst heterologous genes
are highlighted in red. Dashed arrows
highlight undesirable side‐products; the
structures of the two well‐characterized
by‐products, OCT and iso‐OCT are shown.
GGPP. geranylgeranyl diphosphate; T5αol,
taxadien‐5α‐ol; TASY, taxadiene synthase;
TAT, taxadien‐5‐alpha‐ol O‐acetyltransferase
[Color figure can be viewed at
wileyonlinelibrary.com]
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1p‐TASY‐GFP; ARS1622b::GAL1p‐MBP‐TASY‐ERG20; ARS1114a::TDH-
3p‐MBP‐TASY‐ERG20) was originally derived from laboratory strain
CEN.PK2‐1C (EUROSCARF) and has been described in more detail
elsewhere (Nowrouzi et al., 2020; Reider Apel et al., 2016). Strain LRS6
was constructed through the addition of gene sequences encoding
CYP725A4, its cognate cytochrome P450 reductase (CPR) enzyme
and TAT obtained from Taxus cuspidata. The synthetic genes were
codon optimized for S. cerevisiae expression and synthesized by In-
tegrated DNA Technologies. The resulting sequences, all required
primers, and single‐guide RNA (sgRNA) oligonucleotides were also
synthesized by Integrated DNA Technologies. Chromosomal integra-
tion of transcriptional units was achieved using a cloning‐free,
Cas9‐aided, homologous recombination method as reported by
(Reider Apel et al., 2016). In summary, 2 μ plasmids expressing both
Cas9 and the selected sgRNA were used. The URA3 selection marker,
carried by the plasmid facilitated successful transformant selection on
CSM‐Ura medium agar plates. For verification of genomic integrations,
Sanger sequencing (Edinburgh Genomics) and Next Generation Se-
quencing (NGS) were used. MinION NGS platform (Oxford Nanopore
Technologies) was used for whole‐genome sequencing along with the
rapid library preparation kit, SQK‐RAD004. Bioinformatics analysis
was carried out by using pomoxis and medaka software and Python.
The transformation was performed according to the LiAc/SS carrier
DNA/PEG method (Gietz & Schiestl, 2007). All chemicals were pur-
chased from Fisher Scientific at the highest available purity unless
otherwise stated.
2.2 | Shake flask cultivations
The LRS6 strain was cultivated in 250ml Erlenmeyer flasks for 3
days. Inocula preparation was achieved by transferring single co-
lonies to 5ml of rich YPD medium (1% yeast extract; 2% peptone;
and 2% glucose) and incubating at 30°C and 250 rpm overnight.
Aliquots of each preculture were subsequently diluted with YP sup-
plemented with 2% galactose to yield a 20ml culture with initial
optical density (OD)600 = 1. A 20% dodecane overlay was added to
give a final working volume of 25ml. Duplicate measurements of
biomass were performed for triplicate shake flasks twice daily. Tax-
ane production was analyzed via gas chromatography‐mass spec-
trometry (GC‐MS) at the end of the cultivation.
2.3 | Microscale high‐throughput bioreactors
For the high‐throughput screening, a BioLector Pro (mp2‐labs)
microbioreactor‐screening platform was utilized. The microbial cul-
tures were performed in triplicate in YP medium supplemented with
one of eight sugar solutions (Table 1), each representing one of the
conditions explored. Inocula were prepared as described for the
shake flasks. Aliquots of the appropriate preculture were diluted
eightfold to a volume of 800 µl in each well with the medium in-
dicated in the experimental design (Table S3). A 200‐µl dodecane
overlay was also added to each well giving a total working volume of
1ml. The temperature was maintained at 30°C under agitation of
1000 rpm with a shaking diameter of 3 mm in 48‐well FlowerPlates
(mp2‐labs). Temperature, biomass, dissolved oxygen (DO), and pH
were monitored online using the inbuilt optical sensors. Taxane
production was analyzed via GC‐MS at the end of the cultivation.
2.4 | Bioreactor conditions
Larger scale cultivations were conducted in MiniBio500 bioreactors
(Applikon Biotechnology) with a working volume of 250ml or 1 L
BIOSTAT Q plus bioreactors (Sartorius‐Stedim Biotech S.A.) with a
working volume of 500ml. Preinoculum cultures were prepared by
transferring from a single colony to 5ml of YPD and incubating at
30℃ and 250 rpm for 8 h. The resulting culture was subsequently
used to inoculate a secondary culture to an OD600 = 1 and incubated
overnight. An aliquot of the resulting culture was diluted with 2% (w/v)
galactose medium to give a 200 (MiniBio 500) or 400ml (BIOSTAT)
culture with an initial OD600 = 1.
To prevent excess foam production polypropylene glycol P2000
(Alfa Aesar) was added to a concentration of 0.01% (v/v) and a
Rushton turbine was placed at the medium‐air interface. A 20% do-
decane overlay was also added. Temperature, DO, and pH were
measured online. The adaptive my‐control system (Applikon Bio-
technology) was used to control process parameters in the MiniBio
500 bioreactors. A setpoint of 30% saturation for DO was applied
and the culture temperature was maintained at 30℃. Where pH
control was implemented, pH was maintained above six through the
automatic addition of 1M NaOH. Where biomass was measured
online, a BE2100 OD scanner (BugLab) was employed, and offline
measurements were performed twice daily using a Nanodrop 2000c
spectrophotometer (Thermo Fisher Scientific). MFCS software (ver-
sion 3.0, Sartorius‐Stedim Biotech S.A.) was employed to control the
BIOSTAT cultivation, pH was maintained at six through the auto-
matic addition of 2M NaOH or 2M H2SO4, and temperature was
TABLE 1 Media compositions investigated during high‐throughput
screening experiments
Total sugar
concentration
(%; w/v)
Yeast
extract
(g/L)
Peptone
(g/L)
Ratio of
glucose to
galactose
2 10 20 0:100
2 10 20 10:90
2 10 20 50:50
4 10 20 0:100
4 10 20 10:90
4 10 20 50:50
0.2 10 20 10:90
0.4 10 20 10:90
4 | WALLS ET AL.
maintained at 30℃. A constant airflow of 1 vvm was maintained and
stirrer speed was adjusted to maintain DO above 30%. Off‐gas
analysis was performed online via mass spectrometry (Prima Pro,
Thermo Fisher Scientific). Samples were taken twice daily for taxane
and metabolite quantification via GC‐MS and high‐performance li-
quid chromatography (HPLC).
2.5 | Taxane and metabolite identification and
quantification
Taxane identification and quantification was achieved via GC‐MS.
The organic dodecane layer was separated from the culture medium
through centrifugation and a 1‐μl sample was injected into a TRACE™
1300 Gas Chromatograph (Thermo Fisher Scientific) coupled to an
ISQ LT single quadrupole mass spectrometer (Thermo Fisher Scien-
tific). Chromatographic separation was achieved using a Trace Gold
TG‐SQC gas chromatography column using a previously described
method (Nowrouzi et al., 2020). To identify and quantify the pro-
duction of compounds by LRS5 and LRS6 (Figure S1), pure standards
of taxadiene, kindly supplied by Baran Lab (The Scripps Research
Institute) and GGOH, obtained from Sigma Aldrich (Gillingham), were
used. Additional product concentrations were estimated relative to
standard taxadiene concentrations. In the BIOSTAT cultivation,
ethanol, acetate, and glycerol production were analyzed via ion‐
exchange HPLC. Following filtration using a 0.45‐μm filter, 20‐μl
samples were injected into a Bio‐Rad Aminex HPX‐87H column for
analysis. The eluent was 5mM H2SO4, flowrate 0.6 ml/min, and the
temperature was 60°C. A RID‐detector was used for quantification.
2.6 | Statistical analysis
Design of experiments and statistical analyses were performed using
Minitab 17 statistical software. A balanced analysis of variance was
used to determine whether investigated factors yielded a significant
impact on measured variables in the microscale yeast cultures. The
null hypothesis considered that there was no significant difference
between the cultures, hence if p ≤ .05 the null hypothesis was
rejected. Pearson's correlation coefficient was used to assess linear
relationships between variables.
3 | RESULTS AND DISCUSSION
3.1 | Strain construction
Taxadiene synthesis is the first committed step in the Taxol biosyn-
thetic pathway and has been achieved in batch cultivation of S. cer-
evisiae with maximum taxadiene titers of 129 and 57mg/L at 20°C
and 30°C, respectively (Nowrouzi et al., 2020). The oxygenation step
in the microbial host was achieved in this study through the chro-
mosomal integration of T. cuspidata CYP725A4 and CPR genes in
tandem into locus 511b. The TAT gene, also originating from T. cus-
pidata, was integrated into locus RKC3 to construct the subsequent
acetylation step. In the native host genome, locus 511b is located in
chr V: 175.892–175.911 on the forward strand, locus RKC3 is lo-
cated in chr III: 119.278–119.313 on the forward strand and both of
the loci are in intergenic regions. The GAL1 promoter was selected to
maximize expression for both CYP725A4 and TAT. Expression of the
CPR enzyme has been shown to be typically approximately 15‐fold
lower in its native host (Jensen & Møller, 2010), as disruption of the
degree of coupling between the CPR and P450 enzymes increases
the generation of toxic reactive oxygen species (Zangar et al., 2004).
To minimize this effect, a single copy of CPR was expressed under the
weaker GAL3 promoter. Zhou et al. (2015) highlighted the acetyla-
tion step by TAT to be the bottleneck of the early pathway, therefore
the stronger GAL1 promoter was also selected for this gene as well
as terminator CYC1. The construction of the genetic parts integrated
into the chromosome of LRS6 is shown in Figure 2.
3.2 | Shake flask cultivation performance and
enzyme characterization
To facilitate preliminary product and growth profile characterization,
the constructed LRS6 strain was grown in shake flask cultures were
the biomass kinetics and final product profile shown in Figure 3a.
F IGURE 2 Construction of T5αAc pathway in Saccharomyces cerevisae. Genes CYP725A4 and CPR were chromosomally integrated in tandem
into locus 511b to facilitate T5αol biosynthesis. TAT was subsequently integrated into locus RKC3 for the acetylation of T5αol to T5αAc. T5αol,
taxadien‐5α‐ol; TAT, taxadien‐5‐alpha‐ol O‐acetyltransferase [Color figure can be viewed at wileyonlinelibrary.com]
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Biomass accumulation by LRS6 reached a final OD600 of
22.0 ± 1.6 after 71 h of culture, cultivation of the parent LRS5 strain
under the same experimental conditions resulted in a substantially
higher OD600 of 36.0 ± 1.8 in just 48 h (Figure S2). In a similar pre-
vious study, LRS5 biomass accumulation was also found to be 40%
higher in shake flask culture (Nowrouzi et al., 2020). The reduced
growth rate observed in the LRS6 strain is therefore likely to be
associated with the increased oxidative stress associated with the
expression of the additional enzymes. A similar effect was observed
when the CYP725A4 and cognate CPR genes were incorporated into
an optimized taxadiene‐producing E. coli strain, biomass accumula-
tion declined by over 50% (Ajikumar et al., 2010).
GC‐MS analysis of the dodecane extracts from LRS6 cultures in
this study confirmed the functional expression of both the TASY and
CYP725A4 genes as shown in Figures 3a and S7a. A total of six
oxygenated products were produced by the strain in addition to the
TASY products. The peaks at 8.34, 8.57, and 8.71min were identified
as iso‐OCT, OCT, and T5αol through comparison of the gas chro-
matographs and mass spectra (Figures S5 and S6) to those reported
in the literature (Edgar et al., 2016; Sagwan‐Barkdoll & Anterola,
2018). When expressed in E. coli, OCT and iso‐OCT were previously
found to be the major products of CYP725A4 (Edgar et al., 2016;
Sagwan‐Barkdoll & Anterola, 2018; Yadav, 2014). In this study,
however, a novel oxygenated diterpenoid with a retention time of
8.49min (diterpenoid 1, Figure S7a) was the major product with a
titer of 7 ± 0.2 mg/L. The mass spectrum for this compound showed a
high level of similarity to that of T5αol (Figure S5), suggesting iso-
merism, however, further characterization is necessary to confirm
this. An additional unknown oxygenated diterpenoid compound was
eluted after 10.03min (diterpenoid 2, Figure S7a) with characteristic
peaks at m/z 55, 105, 138, 273, and 288 (Figure S6). The CYP725A4
enzyme, like many cytochrome P450 enzymes, has been shown to be
multispecific in addition to highly promiscuous. The enzyme's activity
on taxadiene, iso‐taxadiene, and at least one mono‐oxygenated tax-
ane has been reported (Edgar et al., 2016; Jennewein et al., 2004;
Yadav, 2014). An additional component was eluted at 9.41 min with a
molecular ion (M+) peak (m/z) of 304. This was equivalent to tax-
adiene (Mr = 272 g/mol) plus O2 (Mr = 32 g/mol) and was therefore
tentatively identified as a taxadiendiol.
The nature of the majority of the side‐products generated from
CYP725A4 was similar to those previously reported (Edgar et al.,
2016; Sagwan‐Barkdoll & Anterola, 2018; Yadav, 2014). However,
the appearance and predominance of a potential T5αol isomer (di-
terpenoid 1) was novel. The expected TAT product, taxa‐4(20),11‐
dien‐5α‐yl acetate (T5αAc), was not detected. This was believed to be
due to insufficient substrate availability as the maximum T5αol titer
achieved under these conditions was just 1 ± 0.1mg/L. Subsequent
experiments therefore focussed on the overproduction of the tax-
adiene and T5αol precursors.
3.3 | Microscale high throughput optimization
To maximize process insight and understanding, the BioLector Pro
(mp2‐labs) microbioreactor‐screening platform was coupled with a
design of experiments approach for the high‐throughput screening of
bioprocessing conditions. A multilevel full‐factorial experiment was
employed to analyze the effects of three key factors on taxane ac-
cumulation: yeast strain, total sugar concentration, and glucose
content (Table S3). Both yeast strains were initially cultivated at two
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different total sugar concentrations, 2% and 4%, to evaluate the ef-
fect of sugar concentration and overflow metabolism on the pro-
duction of taxanes. As the overexpression of the native mevalonate
pathway and heterologous expression of TASY, CYP725A4, CPR, and
TAT relied on GAL promoters, the addition of galactose was required
for taxane production. In this study, LRS5 and LRS6 were cultivated in
pure galactose along with 10:90 and 50:50 mixtures of glucose and
galactose to determine the optimum for biomass and taxane accu-
mulation. The bioreactor results and final product profile of the high‐
throughput microscale screening are summarized in Figures 4 and 5,
respectively.
3.3.1 | Microscale biomass kinetics
It can be clearly seen in Figure 4a that when sugar concentration was
increased from 2% to 4% for the TASY strain (LRS5), a significant
increase in final OD600 was observed from 47.8 ± 4.2 to 70.4 ± 5.6,
respectively. A similar effect was seen in the LRS6 cultures; however,
as in the shake flask cultivations (Figure 3), the final biomass
concentrations were lower than for the LRS5 cultures, at 42.3 ± 1.3
and 54.3 ± 7.2 for 2% and 4% sugar cultures, respectively due to the
expression of CYP725A4, CPR, and TAT. Supplementation of the cul-
tures with glucose resulted in no significant improvement in final
biomass yield for both strains under all conditions tested. As expected,
the rate of growth for the pure galactose cultures was slower than
that of equivalent glucose‐containing cultures with a longer cultivation
time being required to reach the stationary phase of growth.
3.3.2 | Taxane product profiles using microscale
bioreactors
The LRS5 strain produced a maximum taxadiene titer of 137 ± 5 g/L
when grown in 4% galactose (100:0) medium. This represented 1.06
and 2.5‐fold improvements in taxadiene titer to 137 ± 5m g/L com-
pared with the highest literature titers for the strain at 20 and 30°C
(Nowrouzi et al., 2020). Although TASY activity has been found to be
enhanced at reduced temperature (Nowrouzi et al., 2020), pre-
liminary studies (results not shown) using LRS6 revealed that
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CYP725A4 activity was dramatically reduced at 20°C compared with
30°C. In addition, both growth rate in S. cerevisiae (Nowrouzi et al.,
2020) and CYP725A4 activity in E. coli (Biggs et al., 2016) have been
found to be reduced at a lower temperature. This study, therefore,
focussed on strategic optimization to ensure high taxadiene titers at
30°C. The highest concentration of oxygenated taxanes was also
achieved for LRS6 grown in the 4% galactose (100:0) medium at
51mg/L, representing a 1.5‐fold increase compared with the highest
concentration reached using the E. coli/S. cerevisiae consortium sys-
tem (Zhou et al., 2015). Although the qualitative nature of the LRS6
taxane products was highly similar to those observed in the shake
flask cultures, the quantitative product profiles differed considerably
between the two scales which can be clearly seen in Figure S7a and
S7c. Similar variations in CYP725A4 selectivity in response to
changes in processing conditions, including microbial host, growth
media, and extraction method have been observed previously (Edgar
et al., 2016). An additional compound with a retention time of
9.28min was observed in the optimal BioLector cultivation (Figures
S7c and S8), showing a high degree of similarity to the published
mass spectrum of geranylgeranyl acetate (GGAc; Walker et al., 1999).
The endogenous GGOH side‐product which was observed in this
study has been previously shown to be a substrate of TAT, the
product of which is GGAc. The presence of GGAc here indicated
potential functional expression of TAT, however, the desired TAT
product, T5αAc, was still not detected.
Mixed glucose and galactose carbon sources (2% [90:10]) have
been previously found to enhance the production of an alternative
heterologous isoprenoid, amorphadiene, in S. cerevisiae, (Paradise
et al., 2008). However, in this study, it can be clearly seen in Figure 5a
that increasing the glucose content generally hindered the produc-
tion of the different oxygenated and nonoxygenated taxanes by both
strains significantly. For example, when using LRS5 with 2% (w/v) of
carbon source with 10% and 50% of glucose content, the taxane
titers declined by 28% and 90% in comparison with using pure ga-
lactose. A similar trend was observed when using 4% (w/v) of carbon
source for the synthesis of oxygenated and nonoxygenated taxanes
by LRS5 and LRS6.
It was, therefore, concluded that pure galactose was the most
appropriate carbon source for taxane production. This was expected
as the GAL promoters are actively repressed by glucose and ga-
lactose is required for their induction. In addition, a reduction in
overflown metabolism may have resulted from the slower growth
rate of S. cerevisiae on galactose (Perez‐Samper et al., 2018). As
taxane production relies on products of aerobic respiration, this may
also contribute to higher taxane titers, however, further research is
required to confirm this. Increasing the initial sugar concentration
from 0.4% to 2% galactose improved LRS5 taxadiene titers 3.5‐fold.
However, when the initial concentration was doubled further to 4%,
an increase in taxadiene titer of just 20% was obtained. The higher
sugar concentration also favored the side reaction converting the
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GGPP precursor to GGOH, the titer of which increased twofold when
cultures were supplemented with 4% pure galactose in comparison
with 2%. To maximize flux through the desired pathway and minimize
undesirable endogenous product formation, the 2% pure galactose
medium was selected for subsequent cultivations.
3.3.3 | Microscale pH kinetics
Fermenting yeasts typically acidify their growth medium through a
combination of proton pumping, organic acid secretion as well as
carbon dioxide evolution, and dissolution (M. G. Walker & Stewart,
2016). This effect was observed for the two S. cerevisiae strains of this
study, as shown in Figure 4c,d, in cultivations supplemented with 2%
or 4% sugar. Acidification occurred during the first 10 h and was
most significant in the 2% and 4% 50:50 galactose to glucose mix-
tures where the pH dropped to 5.9 ± 0.07 and 5.7 ± 0.02, respec-
tively. This was expected as glucose is fermented at a faster rate than
galactose by S. cerevisiae and organic acids such as acetic acid are
secreted as side‐products of fermentation (Martinez et al., 2014).
Despite this, alteration of the sugar composition had no significant
difference in the final pH values of the cultures supplemented with
2% or 4% sugar (p = .159). Acidification was negligible for cultures
supplemented with 0.2% or 0.4% sugar, likely due to reduced fer-
mentative metabolism.
3.3.4 | Microscale dissolved oxygen kinetics
High DO concentrations (>80%) were observed throughout the cul-
tivation for all conditions explored as shown in Figure 4e,f, indicating
excellent oxygen mass transfer. However, the use of organic solvents
is not recommended with FlowerPlates (m2p‐labs, 2019), as the de-
gradation of the DO sensor could occur. As a result, further experi-
ments were conducted without a dodecane overlay to characterize
the effect. DO concentration readings for the cultures with and
without the overlay were similar with between 87% and 96% DO
being maintained throughout the cultivation (Figure S9). The high
oxygen transfer rate observed was, therefore, likely due to the use of
the novel baffled FlowerPlates, which have been found to improve
kLa values twofold at 800 rpm compared with traditional round well
microtiter plates (Funke et al., 2009), eliminating oxygen limitation in
S. cerevisiae cultures.
3.4 | Process validation
3.4.1 | Scale‐up of optimal microscale conditions
During high throughput microscale screening, 2% pure galactose
medium was deemed optimal for maximizing flux through the het-
erologous taxol pathway and minimizing undesirable endogenous
product accumulation. A scale‐up of this condition was subsequently
performed to predict the industrial scale performance of LRS6. This
was achieved using a 500‐ml benchtop MiniBio 500 bioreactor
(Applikon Biotechnology) with a total working volume of 250ml,
representing a 250‐fold scale up. The results of this experiment are
summarized in Figure 6.
The total taxane product titers at micro and minibioreactor scale
were highly similar at 95 ± 18 and 99mg/L, respectively. However,
the final concentration of the potential T5αol isomer was reduced
substantially from 24 ± 4 at microscale to 9mg/L using the
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minibioreactor. Oxygenated taxane compounds accounted for just
21% of the total products in the bioreactor compared with 41 ± 4% at
microscale. Although acidification was observed in the microscale
cultivations as shown in Figure 4c,d, it was much more significant in
the bioreactor cultivation (Figure 6a). This likely contributed to the
poor performance observed for the synthesis of oxygentated tax-
anes, as the optimal pH for the membrane‐bound CYP725A4 has
been reported to be 7.2 in its natural source, with activity dropping
by 50% at pH 6.2 (Hefner et al., 1996). This may have been further
exacerbated by the instability of NADPH at reduced pH, the rate of
degradation of which increases as the pH decreases below 7.5, re-
ducing electron availability, and potentially the activity of the re-
ductase enzyme (Wu et al., 1986). According to a study by (Valli et al.,
2005), the internal pH of S. cerevisiae varies with external pH. For
exponentially growing cells cultivated in media buffered to pH 5.0
and 7.0, the internal pH values were around 6.3 and 7.1, respectively
(Valli et al., 2005). The pH of the culture decreased from 6.6 to 4.9,
suggesting that the internal pH likely dropped below 6.3. Whereas in
the microscale cultures, the minimum external pH was 5.9 ± 0.1
corresponding to an internal pH of approximately 6.7. The significant
drop in pH observed in the bioreactor could therefore likely be re-
sponsible for the dramatic reduction in CYP725A4 activity. As a re-
sult, pH control was deemed necessary in future runs.
The OD600 plateaued at 37.0 (~6.72 g/L) in the stationary phase
of growth as shown in Figure 6a, this was similar to the final value of
35.5 ± 8.7 (~6.44 ± 1.58 g/L) obtained for the same medium in the
microscale bioreactor (Figure 4b). The ability of the BioLector to
effectively mimic larger‐scale cultivation performance has been de-
monstrated previously by Back et al., (2016). Although oxygenated
taxane titers were lower at bioreactor scale in the study, biomass and
total taxane concentrations were highly comparable.
3.4.2 | Effect of external pH
Although S. cerevisiae is capable of proliferating across a broad pH
range, its growth rate is optimal between pH 4–6 (Narendranath &
Power, 2005) and is decreased substantially above pH 8 (Peña et al.,
2015). As there was a significant difference in optimal pH for the
enzyme and host, an additional microscale study was conducted to
evaluate the effect of pH on both taxane and biomass accumulation
by LRS6 as shown in Figure 7a,b.
The initial pH of the culture medium was buffered to seven
through the addition of potassium buffer, which had a negative effect
on both biomass and taxane accumulation. The final OD600 was
15.8 ± 2.2 compared with 37.1 ± 4.4 without the buffer as shown in
Figure 7a. The titers of taxadiene and novel oxygenated diterpenoid
1 were also considerably lower at 4 ± 2 and 6 ± 2mg/L compared
with 20 ± 5 and 22 ± 6mg/L for the nonbuffered cultures. The pre-
liminary bioreactor results (Figure 6) indicated that although lower
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pH (<5.0) did not impair cell growth, it was detrimental to CYP725A4
activity. Higher pH (>6.5) hindered yeast growth and also led to
lower oxygenated taxane titers. Although temporal monitoring of
taxane accumulation was not possible at microscale due to limited
culture volumes, statistical analysis of the MiniBio scale kinetics re-
vealed a strong positive correlation between OD600 and taxane titer
(Pearson's r = .8916, Figure 6). A compromise was therefore neces-
sary to maximize both taxane and biomass accumulation. The non-
buffered culture dropped to around pH 6.0 as shown in Figure 7a and
resulted in significantly higher total taxane titers. In addition, pH 6.0
has been shown to be the upper limit of the optimal range for yeast
growth (Narendranath & Power, 2005). A pH of 6.0 was, therefore,
implemented in the subsequent bioreactor cultivation, the data for
which is summarized in Figure 7c,d. During the first 12 h of cultiva-
tion, a fivefold increase in biomass was observed, followed by a lag
phase in the subsequent 12 h. A similar effect was observed in the
shake flask (Figure 3a) and microscale cultures (Figure 4). This lag
phase is characteristic of S. cerevisiae cultures as the carbon source is
switched from glucose to galactose. The growth observed in the in-
itial 12 h is, therefore, likely to have been the result of an additional,
more preferable carbon source within the growth medium such as
residual glucose from the inoculum or carbohydrates present in the
complex yeast extract medium. The final OD600 values for the initial
cultivation without pH control (Figure 6a) and subsequent controlled
cultivation (Figure 7c) were comparable at 38.9 and 34.5, respec-
tively. When the pH was controlled above six in the minibioreactor
(Figure 7d), the total product titer was 50% lower (56.0 mg/L) than
that obtained in the absence of pH control (98.9 mg/L, Figure 6b).
Despite this, the titer of diterpenoid 1 increased significantly from
8.9 (Figures 6b) to 19.2 mg/L (Figure 7d), confirming increased
CYP725A4 activity at higher pH. Statistical analysis confirmed a
strong positive correlation between total taxane concentration and
OD600 in the pH‐controlled bioreactor (Pearson's r = .9625). A pH of
6 was therefore selected for subsequent cultivations to maximize
accumulation of both. This highlights the importance of integrating
critical process parameter control in the early stages of the
design–build–test–learn cycle to ensure effective microbial cell fac-
tory construction and optimization.
3.4.3 | Detection of taxadien‐5α‐yl‐acetate
GGAc was detected during the microscale optimization study, in-
dicating potential TAT activity, however, it was not detected in the
bioreactor or shake flask cultures. TAT relies on acetyl‐CoA as a
substrate, a major product of aerobic respiration. One of the key
advantages of the baffled FlowerPlates employed in the microscale
optimization study is excellent oxygen mass transfer (m2p‐labs,
2019), which eliminated oxygen limitation. Although DO was con-
trolled above 30% saturation through air sparging in the bioreactor,
oxygen availability was likely reduced compared to the FlowerPlate.
As galactose metabolism is respiratory‐fermentative, it was hy-
pothesized that increasing oxygen availability through constant
airflow at bioreactor scale may increase flux through aerobic re-
spiration and hence acetylated taxane production. The optimized
conditions were scaled up further using highly instrumented 1 L
BIOSTAT bioreactors, with a constant airflow of 1 vvm, to facilitate
further characterization. The results of this experiment are sum-
marized in Figure 8.
As in previous cultivations an initial growth phase was observed.
During the first 22 h of growth the OD600 increased from 1 to 14.4
(Figure 8a). Following this a lag phase was observed and ethanol
production initiated. At around 48 h, the ethanol concentration
reached a maximum of 2.7 g/L (Figure 8a) and the oxygen uptake rate
began to increase (Figure 8c). This indicated a switch from pre-
dominantly fermentative metabolism of galactose to aerobic re-
spiration. Growth proceeded via respiration of ethanol and acetate
with a maximum OD600 of 34.6 (~6.28 g/L) being reached at around
72 h, highly comparable with the 34.5 (~6.26 g/L) obtained in the
500ml bioreactor (Figure 7c). The rate of biomass and taxane ac-
cumulation was greatest between 48 and 72 h. At 72 h the metabo-
lizable carbon sources, galactose, ethanol, and acetate had been
exhausted and the stationary phase of growth was reached
(Figure 8a). In the final 48 h of cultivation, a slight increase in total
taxane concentration from 154 to 171mg/L was observed despite
the cells being in the stationary phase of growth. Previous work
indicated that some taxadiene may be retained intracellularly and
secreted during the stationary phase of growth (Nowrouzi et al.,
2020). The observed increase in taxane concentration may have,
therefore been the result of secreted intracellular taxanes. An
alternative extraction procedure incorporating a cell lysis step could,
therefore allow similar titers to be achieved in a shorter cultiva-
tion time.
Closer inspection of the mass spectrum of the suspected tax-
adiendiol compound produced in previous cultivations (Figure S6c)
revealed peaks at m/z = 255, 270, and 287 in addition to the char-
acteristic taxadiendiol peaks at m/z = 286 and 304. These peaks have
not been reported in other taxadiendiol mass spectra, however, such
peaks have been found diagnostic of T5αAc (255: P+‐CH3COOH‐
CH3, 270: P
+‐CH3COOH, and 287: P+‐CH3CO; Walker et al., 1999). It
was, therefore, further hypothesized that the two compounds may be
coeluting. According to the fundamental resolution equation, in-
creasing the length of the chromatography column generally im-
proves separation, therefore, in this study, a 30‐m column was used
in place of the 15‐m column used in previous results. This success-
fully improved chromatographic separation as shown in Figure S10b.
An additional four potential diterpene and two potential diterpenoid
compounds were detected (Figures S10b and S13). The taxadiendiol
peak was successfully separated into two peaks with retention times
of 11.89 and 11.91, respectively, however, there was overlapping
observed indicating resolution could be improved further. The mass
spectrum of the compound eluted at 11.89min (Figure S11) was al-
most identical to that of T5αAc published in literature (Edgar et al.,
2016; Walker et al., 1999) with the exception of a peak at m/z = 245.
The peak at 11.91 contained the diagnostic taxadiendiol peaks at
m/z = 304 and 286 along with a large base peak at m/z = 245
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(Figure S12). An extracted ion chromatogram was generated for
m/z = 245, this revealed a large single peak at 11.91min (Figure
S10a). This indicated that the peak at m/z = 245 was most likely the
result of overlapping rather than the compound eluted at 11.89min.
The compound eluted at 11.89min was, therefore, tentatively iden-
tified as T5αAc. Quantification was performed relative to the tax-
adiene standard and the resulting final T5αAc titer was 3.7 mg/L,
representing a fourfold improvement in acetylated taxadiene in
S. cerevisiae in comparison with the previous literature (Zhou et al.,
2015). Diterpene 2 was not detected using the optimized GC‐MS
protocol, however, an additional four diterpene compounds
(diterpene 3, diterpene 4, diterpene 5, and diterpene 6, Figure S10b)
were detected between taxadiene and iso‐OCT. This suggests that
the previously identified diterpene 2 compound may have also been
two or more of the additional diterpene products coeluting.
3.5 | Comparison of the systems studied
The simultaneous expression of TASY, CYP725A4, CPR, and TAT was
found to be sensitive to deviations in processing conditions at dif-
ferent production scales. Variations in both the titer and product
composition were observed as summarized in Figures 9 and S7. The
results obtained using the BioLector and uncontrolled MiniBio 500
systems were highly comparable for the LRS6 strain. The final OD600
values were 42.3 ± 1.3 (~7.68 ± 0.24 g/L) and 38.9 (~7.06 g/L), and the
total product titers were 95 ± 18 and 99mg/L for the micro and
minibioreactor systems, respectively. However, both oxygenated
taxane and GGOH production were reduced in the bioreactor culti-
vation. The CYP725A4 enzyme was found to be very sensitive to
deviations in process conditions between the two scales. To compare
selectivity across the systems studied, the yield of each product as a
percentage of the total products was plotted as shown in Figure 9a.
The total nonoxygenated and oxygenated taxane titers were also
plotted in Figure 9b. The products of most interest were iso‐
taxadiene, taxadiene, diterpenoid 1, T5αol, and T5αAc, due to their
active role in the Taxol biosynthetic pathway. Variation in selectivity
towards these compounds across scales was, therefore also sum-
marized in Figure 9c.
The major products of TASY and CYP725A4 were found to be
taxadiene and the novel potential T5αol isomer, diterpenoid 1,
respectively, under all of the conditions explored. However,
selectivity towards the minor enzymatic products varied con-
siderably, with varying quantities of the additional side‐products
of the enzymes being produced as shown in Figure 9. Although the
BioLector facilitated the monitoring of critical process parameters
including pH and DO, control of such parameters was not prac-
ticable. This was particularly problematic for strain LRS6 as
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CYP725A4 activity was found to be negatively affected by sub-
optimal pH. Increased acidification in the uncontrolled bioreactor
cultivation resulted in a 50% reduction in oxygenated taxane titer
as shown in Figure 9b, despite highly comparable overall taxane
titers. Although controlling the pH to a setpoint of 6 improved
oxygenated taxane titers dramatically in subsequent cultivations,
the final taxadiene titers were 10 and 54 mg/L for the pH‐
controlled MiniBio and BIOSTAT cultivations, respectively, in-
dicating that CYP725A4 activity could be improved further. As the
enzyme performs optimally at higher pH, increasing the pH of the
culture medium in the final stages of the cultivation may improve
conversion of taxadiene to T5αol; however, further research is
required to confirm this. A small quantity of GGAc was detected in
the BioLector cultivations indicating functional TAT expression.
Through a combination of bioprocess optimization and improved
GC‐MS resolution at increased scale it was possible to detect the
desired T5αAc compound. The resulting cultivation incorporated
the optimized 2% galactose medium, pH setpoint of 6, and con-
stant air supply at 1 vvm leading to a maximum titer of 3.7 mg/L.
The oxygenated taxane titer was also improved 2.4‐fold to
78 mg/L compared with the highest reported titer for the E. coli/S.
cerevisiae consortium system (Zhou et al., 2015). To our knowl-
edge, this is the first time acetylated taxanes have been success-
fully produced in an individual S. cerevisiae strain.
4 | CONCLUSION
In this study, critical factors affecting CYP725A4 enzymatic perfor-
mance in an engineered S. cerevisiae strain were elucidated across a
range of scales, providing a foundation for the development of robust
integrated bioprocess control systems. Optimized cultivation of the
engineered S. cerevisiae strain with three copies of taxadiene syn-
thase (LRS5) in the FlowerPlates facilitated 1.06 and 2.5‐fold im-
provements in taxadiene titer to 137 ± 5 g/L compared with the
highest literature titers for the strain at 20 and 30°C (Nowrouzi et al.,
2020). In this study, strategic optimization ensured high taxadiene
titers at 30°C, thereby eliminating reliance on suboptimal cultivation
temperatures. In contrast to bacterial systems in which the by‐
products OCT and Iso‐OCT were the major products of CY725A4
(Edgar et al., 2016), when expressed in the S. cerevisiae strain, a novel
potential T5αol isomer (diterpenoid 1) was the predominant product
with maximum titers of 24 ± 6 and 31mg/L at micro and 1 L bior-
eactor scale, respectively. Biomass and total taxane titers achieved
using the BioLector were comparable with those achieved in the
MiniBio 500 bioreactor. The online monitoring capabilities of the
BioLector proved invaluable for the primary high‐throughput
screening of wide‐ranging processing conditions. However, as a re-
sult of the vulnerability of the complex cytochrome P450 enzyme to
deviations in external processing conditions, further optimization
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was essential to achieve comparable performance at an increased
scale. Significant discrepancies were identified between the optimal
conditions for the host and the catalytic activity of the different
recombinant enzymes; therefore, a compromise was necessary to
alleviate the key bottlenecks. Despite a 500‐fold scale up in working
volume, through careful control of critical process parameters in-
cluding pH and O2, paclitaxel precursor synthesis was improved
substantially at bioreactor scale in just three experimental runs. Total
oxygenated taxane titers were improved twofold to 78mg/L and the
acetylated T5αAc product was detected for the first time with a final
titer of 3.7 mg/L. This highlights that maximizing process insight from
the earliest stages of the design‐build‐test‐learn cycle is critical to
successful bioprocess development.
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